PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol drug help treat a rare liver disease?
Disease control CompletedThis early-phase study tested whether adding fenofibrate (a cholesterol-lowering drug) to standard treatment with ursodeoxycholic acid improves liver function in 30 adults newly diagnosed with primary biliary cholangitis (PBC), a chronic liver disease. The main goal was to see if…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: EARLY_PHASE1 • Sponsor: Han Ying • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Can breathing and meditation ease PBC symptoms? new study says maybe.
Symptom relief CompletedThis study tested a 10-week online wellness program for women with primary biliary cholangitis (PBC), a chronic liver disease. The program included guided breathing, meditation, gentle movement, and optional nutrition advice. Researchers wanted to see if the program was easy to f…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
New drug PVT201 tested for safety in liver patients
Knowledge-focused CompletedThis early-phase study tested a single dose of PVT201 in 24 people to see if it is safe and how the body processes it. Healthy volunteers and patients with primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC) took part. The goal was to check for side effects …
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE1 • Sponsor: Parvus Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:03 UTC